[Double-blind randomized study comparing ioversol 300 versus iopromide 300 abdominal computed tomography (CT scanner)].
The authors compared ioversol 300 and iopromide 300 (ioversol 41 patients, iopromide 38 patients) in a randomized double blind study conducted on 79 patients undergoing abdominal computed tomography (CT) for a variety of indications. Each study was rated as diagnostic or non-diagnostic and the image quality was recorded. All side-effects were recorded. There was no significant difference in image quality and side-effects between both contrasts. In this study, both ioversol and iopromide provided excellent image quality and a low rate of side-effects. The authors conclude that ioversol is a safe and effective non ionic contrast agent for contrast enhanced body CT.
Hoogewoud
H M
HM
Département de Radiologie, Hôpital Cantonal, Fribourg, Suisse.
Neiss
A C
AC
Woessmer
B
B
D000328:Adult; D004311:Double-Blind Method; D006801:Humans; D007275:Injections, Intravenous; D007472:Iohexol / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D014057:Tomography, X-Ray Computed / Q000379:methods*; D014283:Triiodobenzoic Acids / Q000008:administration & dosage / Q000009:adverse effects
D014283:Triiodobenzoic Acids; D007472:Iohexol; C038192:iopromide; C054871:ioversol
Etude randomisée en double aveugle comparant ioversol 300 et iopromide 300 en tomodensitométrie abdominale (CT-scanner).